Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.
Company | Current Parent | Current Parent Industry | Primary Offense Type | Year | Agency | Penalty Amount |
---|---|---|---|---|---|---|
Acclarent Inc. | Johnson & Johnson | pharmaceuticals | False Claims Act and related | 2016 | DOJ_CIVIL | $18,000,000 |
Pfizer Inc. | Pfizer | pharmaceuticals | False Claims Act and related | 2016 | DOJ_CIVIL | $784,600,000 |
AstraZeneca LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2015 | DOJ_CIVIL | $46,500,000 |
Cephalon Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2015 | DOJ_CIVIL | $7,500,000 |
Genzyme Corp. | Sanofi | pharmaceuticals | False Claims Act and related | 2013 | DOJ_CIVIL | $22,280,000 |
St. Jude Medical Inc. | Abbott Laboratories | pharmaceuticals | False Claims Act and related | 2012 | DOJ_CIVIL | $3,650,000 |
Dava Pharmaceuticals Inc. | Endo International | pharmaceuticals | False Claims Act and related | 2012 | DOJ_CIVIL | $11,000,000 |
Dey Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2010 | DOJ_CIVIL | $280,000,000 |
Roxane Laboratories Inc. | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2010 | DOJ_CIVIL | $280,000,000 |
Abbott Laboratories Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2010 | DOJ_CIVIL | $126,500,000 |
Eon Labs Inc. | Novartis | pharmaceuticals | False Claims Act and related | 2010 | DOJ_CIVIL | $3,500,000 |
AstraZeneca Pharmaceuticals | AstraZeneca | pharmaceuticals | False Claims Act and related | 2009 | DOJ_CIVIL | $2,600,000 |
Mylan Pharmaceuticals and UDL Laboratories | Viatris | pharmaceuticals | False Claims Act and related | 2009 | DOJ_CIVIL | $118,000,000 |
Ortho McNeil Pharmaceutical | Johnson & Johnson | pharmaceuticals | False Claims Act and related | 2009 | DOJ_CIVIL | $3,400,000 |
Aventis Pharmaceutical Inc. | Sanofi | pharmaceuticals | False Claims Act and related | 2009 | DOJ_CIVIL | $95,500,000 |
King Pharmaceuticals | Pfizer | pharmaceuticals | False Claims Act and related | 2005 | DOJ_CIVIL | $124,000,000 |
GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2005 | DOJ_CIVIL | $150,000,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2003 | DOJ_CIVIL | $354,900,000 |
Pfizer Corporation | Pfizer | pharmaceuticals | False Claims Act and related | 2002 | DOJ_CIVIL | $49,000,000 |
Johnson & Johnson Medical, Inc. | Johnson & Johnson | pharmaceuticals | False Claims Act and related | 2001 | DOJ_CIVIL | $3,900,000 |
Sanofi-Pasteur | Sanofi | pharmaceuticals | False Claims Act and related | 2017 | DOJ_CIVIL | $19,868,194 |
Mylan Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2017 | DOJ_CIVIL | $465,000,000 |
SmithKline Beecham | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2003 | DOJ_CIVIL | $47,000,000 |
Schering-Plough Corporation | Merck | pharmaceuticals | drug or medical equipment safety violation | 2002 | DOJ_CIVIL | $500,000,000 |
Dr. Reddy's Laboratories Inc. | Dr. Reddy's Laboratories | pharmaceuticals | drug or medical equipment safety violation | 2018 | DOJ_CIVIL | $5,000,000 |
United Therapeutics Corporation | United Therapeutics | pharmaceuticals | False Claims Act and related | 2017 | DOJ_CIVIL | $210,000,000 |
Alere Inc. | Abbott Laboratories | pharmaceuticals | False Claims Act and related | 2018 | DOJ_CIVIL | $33,200,000 |
Astellas Pharma US Inc. | Astellas Pharma | pharmaceuticals | False Claims Act and related | 2019 | DOJ_CIVIL | $100,000,000 |
Amgen Inc. | Amgen | pharmaceuticals | False Claims Act and related | 2019 | DOJ_CIVIL | $24,750,000 |
DUSA Pharmaceuticals, Inc. | Sun Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2020 | DOJ_CIVIL | $20,750,000 |
Biogen, Inc. | Biogen | pharmaceuticals | False Claims Act and related | 2020 | DOJ_CIVIL | $22,000,000 |
Akorn Operating Company LLC | Akorn Inc. | pharmaceuticals | False Claims Act and related | 2022 | DOJ_CIVIL | $7,900,000 |
Ultragenyx Pharmaceutical Inc. | Ultragenyx Pharmaceutical | pharmaceuticals | False Claims Act and related | 2023 | DOJ_CIVIL | $6,000,000 |
Novo Nordisk A/S | Novo Holdings A/S | pharmaceuticals | kickbacks and bribery | 2009 | DOJ_CRIMINAL | $9,000,000 |
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. | Bausch Health | pharmaceuticals | benefit plan administrator violation | 2016 | EBSA | $10,001 |
BIOVAIL AMERICAS CORP. | Bausch Health | pharmaceuticals | benefit plan administrator violation | 2012 | EBSA | $10,001 |
CHEROKEE PHARMACEUTICALS LLC | Merck | pharmaceuticals | benefit plan administrator violation | 2011 | EBSA | $10,001 |
NOVARTIS PHARMACEUTICALS CORPORATION | Novartis | pharmaceuticals | benefit plan administrator violation | 2006 | EBSA | $10,001 |
IMMUNOMEDICS, INC. EMPLOYEES' 401(K) SAVINGS PLAN | Gilead Sciences | pharmaceuticals | benefit plan administrator violation | 2001 | EBSA | $10,001 |
Seagen Pharmaceuticals, Inc. | Pfizer | pharmaceuticals | benefit plan administrator violation | 2001 | EBSA | $29,974 |
PERNIX THERAPEUTICS, LLC | Currax Pharmaceuticals | pharmaceuticals | benefit plan administrator violation | 2019 | EBSA | $10,001 |
Merck | Merck | pharmaceuticals | environmental violation | 2011 | EPA | $1,500,000 |
King Pharmaceuticals LLC | Pfizer | pharmaceuticals | air pollution violation | 2013 | EPA | $2,200,000 |
GlaxoSmithKline Vaccines | GlaxoSmithKline | pharmaceuticals | air pollution violation | 2014 | EPA | $172,900 |
GlaxoSmithKline LLC | GlaxoSmithKline | pharmaceuticals | hazardous waste violation | 2014 | EPA | $317,550 |
Advanced Sterilization Products | Johnson & Johnson | pharmaceuticals | environmental violation | 2014 | EPA | $136,800 |
Pfizer Pharmaceuticals LLC | Pfizer | pharmaceuticals | air pollution violation | 2014 | EPA | $728,000 |
EMD Millipore Corporation | Merck KGaA (EMD) | pharmaceuticals | pesticide violation | 2013 | EPA | $2,681,500 |
Boehringer Ingelheim Vetmedica, Inc. | Eli Lilly | pharmaceuticals | hazardous waste violation | 2012 | EPA | $68,475 |
Boehringer Ingelheim Vetmedica, Inc. | Eli Lilly | pharmaceuticals | air pollution violation | 2011 | EPA | $300,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | air pollution violation | 2008 | EPA | $3,650,000 |
Pfizer Inc. | Pfizer | pharmaceuticals | air pollution violation | 2008 | EPA | $975,000 |
Merck | Merck | pharmaceuticals | water pollution violation | 2007 | EPA | $19,750,000 |
EMD Millipore Corp. | Merck KGaA (EMD) | pharmaceuticals | environmental violation | 2017 | EPA | $385,000 |
Pfizer Pharmaceuticals, LLC | Pfizer | pharmaceuticals | air pollution violation | 2016 | EPA | $190,000 |
CSL Behring, LLC | CSL Limited | pharmaceuticals | air pollution violation | 2021 | EPA | $527,144 |
Genentech | Roche | pharmaceuticals | hazardous waste violation | 2023 | EPA | $158,208 |
BRISTOL - MYERS SQUIBB MEDICAL IMAGING INC | Bristol-Myers Squibb | pharmaceuticals | air pollution violation | 2009 | EPA | $19,538 |
PFIZER INC / GROTON SITE | Pfizer | pharmaceuticals | environmental violation | 2005 | EPA | $22,500 |
PFIZER GLOBAL MANUFACTURING | Pfizer | pharmaceuticals | air pollution violation | 2008 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $975,000 |
MILLIPORE CORP | Merck KGaA (EMD) | pharmaceuticals | environmental violation | 2010 | EPA | $526,500 |
EMD MILLLIPORE CORP | Merck KGaA (EMD) | pharmaceuticals | environmental violation | 2013 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,681,500 |
EMD MILLIPORE CORPORATION | Merck KGaA (EMD) | pharmaceuticals | water pollution violation | 2017 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $385,000 |
MILLIPORE, CIDRA, INC. | Merck KGaA (EMD) | pharmaceuticals | water pollution violation | 2000 | EPA | $9,000 |
LILLY DEL CARIBE INC | Eli Lilly | pharmaceuticals | environmental violation | 2000 | EPA | $39,000 |
WYETH PHARMACEUTICALS COMPANY - OTC | Pfizer | pharmaceuticals | water pollution violation | 2000 | EPA | $25,000 |
MALLINCKRODT, INC. | Mallinckrodt | pharmaceuticals | water pollution violation | 2000 | EPA | $12,500 |
LILLY DEL CARIBE, INC. | Eli Lilly | pharmaceuticals | water pollution violation | 2000 | EPA | $90,000 |
HI TECH PHARMACAL CO., INC. | Akorn Inc. | pharmaceuticals | water pollution violation | 2001 | EPA | $20,500 |
PHARMACIA & UPJOHN CARIBE | Pfizer | pharmaceuticals | environmental violation | 2001 | EPA | $27,168 |
SCHERING-PLOUGH PRODUCTS LLC | Merck | pharmaceuticals | hazardous waste violation | 2001 | EPA | $54,100 |
SEARLE LTD | Pfizer | pharmaceuticals | hazardous waste violation | 2002 | EPA | $95,000 |
Schering Plough Products | Merck | pharmaceuticals | hazardous waste violation | 2002 | EPA | $49,000 |
Pfizer Pharmaceuticals Ltd. | Pfizer | pharmaceuticals | water pollution violation | 2004 | EPA | $20,025 |
Watson Laboratories, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | water pollution violation | 2004 | EPA | $20,000 |
Lilly Del Caribe, Inc. | Eli Lilly | pharmaceuticals | hazardous waste violation | 2003 | EPA | $68,992 |
Wyeth Ayerst Pharmaceuticals | Pfizer | pharmaceuticals | hazardous waste violation | 2004 | EPA | $37,000 |
Merck & Co. Inc. | Merck | pharmaceuticals | water pollution violation | 2005 | EPA | $33,700 |
Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | air pollution violation | 2009 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,328,154 |
Amgen Manufacturing, Limited | Amgen | pharmaceuticals | water pollution violation | 2006 | EPA | $20,000 |
Pfizer Pharmaceuticals LLC | Pfizer | pharmaceuticals | hazardous waste violation | 2005 | EPA | $55,000 |
Phibro Animal Health Corporation | Phibro Animal Health | pharmaceuticals | environmental violation | 2006 | EPA | $82,467 |
Wyeth Rouses Point | Pfizer | pharmaceuticals | water pollution violation | 2008 | EPA | $44,500 |
Merck Sharp & Dohme Quimica de Puerto Rico | Merck | pharmaceuticals | hazardous waste violation | 2007 | EPA | $10,000 |
Bristol Myers Squibb Company | Bristol-Myers Squibb | pharmaceuticals | air pollution violation | 2008 | EPA | $66,770 |
Bristol Myers Squibb Manufacturing Company | Bristol-Myers Squibb | pharmaceuticals | hazardous waste violation | 2008 | EPA | $52,000 |
Wyeth Pharmaceuticals Company, Inc. | Pfizer | pharmaceuticals | water pollution violation | 2010 | EPA | $77,000 |
E.R. Squibb & Sons LLC | Bristol-Myers Squibb | pharmaceuticals | PCB violation | 2009 | EPA | $8,125 |
Schering Plough Products, LLC | Merck | pharmaceuticals | environmental violation | 2010 | EPA | $11,500 |
Janssen Pharmaceutical (SB) | Johnson & Johnson | pharmaceuticals | environmental violation | 2010 | EPA | $105,000 |
Pfizer Pharmaceuticals | Pfizer | pharmaceuticals | PCB violation | 2010 | EPA | $24,650 |
Schering-Plough Products, LLC | Merck | pharmaceuticals | air pollution violation | 2011 | EPA | $260,000 |
Roche Molecular Systems, Inc. | Roche | pharmaceuticals | hazardous waste violation | 2011 | EPA | $90,000 |
Pfizer Pharmaceuticals, LLC | Pfizer | pharmaceuticals | air pollution violation | 2014 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $728,000 |
Celgene Corporation | Bristol-Myers Squibb | pharmaceuticals | PCB violation | 2013 | EPA | $6,035 |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | hazardous waste violation | 2003 | EPA | $61,158 |
Merck and Company | Merck | pharmaceuticals | water pollution violation | 2008 | EPA | $6,075,000 |
MERCK & CO., INC. | Merck | pharmaceuticals | air pollution violation | 2011 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,500,000 |
NOVOZYMES BIOLOGICALS, INC | Novo Holdings A/S | pharmaceuticals | environmental violation | 2009 | EPA | $26,797 |
MERCK SHARP & DOHME CORPORATION | Merck | pharmaceuticals | environmental violation | 2012 | EPA | $69,274 |
GLAXOSMITHKLINE, LLC | GlaxoSmithKline | pharmaceuticals | hazardous waste violation | 2014 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $317,550 |